22.75 USD
▲+0.48+2.80%
盘后 21.78 -1.58%
2026-08-03
市值
$40.66M
市盈率
—
EPS
-0.55
股息率
—
52 周区间
13.80 – 33.63
成交量
32.86K
Beta
1.28
目标价
—
52W 低 13.8052W 高 33.63
价格走势
公司简介
Precipio, Inc., a healthcare biotechnology company, provides cancer diagnostic products, reagents, and services in the United States. It provides diagnostic blood cancer testing services. The company offers HemeScreen, a suite of robust genetic diagnostic panels; and IV-Cell, a proprietary cell culture media that enables simultaneous culturing of four hematopoietic cell lineages. It offers biomarker testing and clinical project services to bio-pharma customers. Precipio, Inc. is based in New Haven, Connecticut.